Lymph node ratio is inferior to pN-stage in predicting outcome in colon cancer patients with high numbers of analyzed lymph nodes

Table 2 Cancer recurrence and survival according to pN-category and LNR-groups

	Recurrence free patients at 24 months^a	Median DFS in months^b	Median OS in months^b
pN-category
1 (n = 38)	23 (60.5)	26.9 (17.3–40.9)	34.5 (24.4–41.1)
2 (n = 20)	6 (30.0)	13.3 (9.2–19.8)	16.3 (12.1–35.1)
LNR-group
Low (n = 26)	17 (65.4)	26.9 (16.3–43.2)	32.1 (24.4–48.0)
High (n = 32)	12 (37.5)	15.0 (9.2–25.0)	19.9 (12.1–38.1)

DFS Disease-free survival, OS Overall survival, LNR Lymph node ratio
^aWith percentages in parentheses, ^bvalues are median (95% confidence interval)

ISSN: 1471-2482